fulvestrant

A drug used to treat certain types of breast cancer in postmenopausal women. It is also being studied in the treatment of other types of cancer. Fulvestrant blocks estrogen activity in the body and is a type of antiestrogen. Also called Faslodex and ICI 182780.

English dictionary of cancer terms . 2015.

Look at other dictionaries:

  • Fulvestrant — drugbox IUPAC name = 13 methyl 7 [9 ( 4,4,5,5,5 pentafluoropentylsulfinyl)nonyl] 7,8,9,11,12,13,14,15,16, 17 decahydro 6 H cyclopenta [a] phenanthrene 3,17 diol CAS number = 129453 61 8 ATC prefix = L02 ATC suffix = BA03 ATC supplemental =… …   Wikipedia

  • fulvestrant — ful·ves·trant (ful vesґtrənt) an antiestrogen administered by intramuscular injection in treatment of breast cancer …   Medical dictionary

  • Organocopper compound — Lithium diphenylcuprate etherate dimer from crystal structure …   Wikipedia

  • Modulador selectivo de los receptores estrogénicos — En farmacología, un modulador selectivo de los receptores estrogénicos (conocido también por el acrónimo MSRE o en inglés SERM) es un compuesto que se une a los receptores estrogénicos de las células, simulando la actividad de los estrógenos en… …   Wikipedia Español

  • Estrogen — Estriol. Note two hydroxyl ( OH) groups attached to the D ring (rightmost ring) …   Wikipedia

  • Progesterone — Systematic (IUPAC) name Pregn 4 ene 3,20 dione …   Wikipedia

  • Mifepristone — Systematic (IUPAC) name 11β [p (Dimethylamino)phenyl] 17β hyd …   Wikipedia

  • Estradiol — Not to be confused with 17α estradiol. Estradiol Systematic (IUPAC) name …   Wikipedia

  • Progestin — Co inventor Luis E. Miramontes s signed laboratory notebook. October 15, 1951 A progestin is a synthetic[1] progestogen that has progestinic effects similar to progesterone. [2] …   Wikipedia

  • Diethylstilbestrol — Systematic (IUPAC) name 4,4 (3E) hex 3 ene 3,4 diyldiphenol Clinical data AHFS/Drugs.com …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.